Q&A With Labaton Sucharow's Bernard Persky
A slowdown in pharmaceutical inflation is proof that the antitrust work of plaintiffs firms is benefiting consumers, Bernard Persky of Labaton Sucharow LLP tells Law360 in our series of chats with...To view the full article, register now.
Already a subscriber? Click here to view full article